Concepedia

Kelly Zullo

KZ

Statistics

Publications

13

Citations

693

H-Index

12

Active since

2013

Affiliations

Columbia University Irving Medical Center(Current)

Columbia University

University of Pennsylvania

West Cancer Center

University of Tennessee Health Science Center

Kelly Zullo is an author at Columbia University Irving Medical Center specializing in medicine, oncology, and pharmacology.

Publications per year

2013–2021

13

Publications

13

Cellular context of IL-33 expression dictates impact on anti-helminth immunity

Li‐Yin Hung, Yukinori Tanaka, Karl Herbine et al. · Science Immunology · 2020 · 136 citations · Full text

, , +17

TFF3 interacts with LINGO2 to regulate EGFR activation for protection against colitis and gastrointestinal helminths

Nicole Maloney Belle, Yingbiao Ji, Karl Herbine et al. · Nature Communications · 2019 · 93 citations · Full text

, , +17

Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma

Jennifer E. Amengual, Paul Johannet, Maximilian Lombardo et al. · Clinical Cancer Research · 2015 · 91 citations

, , +14

Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma

Salvia Jain, Xavier Jirau-Serrano, Kelly Zullo et al. · Clinical Cancer Research · 2015 · 77 citations · Full text

, , +17

The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T‐cell lymphoma

Enrica Marchi, Kelly Zullo, Jennifer E. Amengual et al. · British Journal of Haematology · 2015 · 67 citations

, , +15

1–5 of 13